{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:54:51Z","timestamp":1782392091807,"version":"3.54.5"},"posted":{"date-parts":[[2026,6,23]]},"group-title":"Neurology","reference-count":50,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["5R01AI144798"],"award-info":[{"award-number":["5R01AI144798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["2U19AI057229"],"award-info":[{"award-number":["2U19AI057229"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Study Objectives<\/jats:title>\n                  <jats:p>Onsets of Narcolepsy type-1 (NT1) increased following A\/H1N1 vaccination with Pandemrix\u00ae in Europe and with A\/H1N1pdm2009 infections in China and other countries. To test if other strains could trigger narcolepsy, we measured strain-specific antibodies in patients with recent onset NT1 compared to controls.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Antibodies against hemagglutinin (HA) and neuraminidase (NA) were tested in 62 patients with very recent onset (onset and blood collection following a single flu season, mean \u00b1 SEM: 0.44 \u00b1 0.06 years since onset) and 100 controls matched by age, sex, season and year of collection (2000-2025). Results were next extended to 181 recent onset patients (mean\u00b1 SEM: 1.00 \u00b1 0.05 years) versus 260 controls, matched by sex, season and year, but having a slightly higher mean age. HA inhibition (HAI) and NA inhibition (NAI) assays were conducted using flu strains known to circulate during the corresponding flu seasons. HAI results are shown as % positive (titers \u2265 40) and NAI results as geometric mean titers. Odds ratio (OR) and \u03b2 coefficient were used to compare antibody titers in NT1 versus controls. The contribution of each assay to prediction was finally quantified in the larger sample set using Shapley decomposition.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    NT1 patients had increased anti-HA and anti-NA antibodies against A\/H1N1pdm2009 (anti-HA OR= 3.86, anti-NA \u03b2= 0.35) and B\/Victoria (anti-HA OR=1.90, anti-NA \u03b2=0.22), but not A\/H1N1pre2009, A\/H3N2, or B\/Yamagata, independent of HLA-DQB1*06:02 status, age, sex, and flu season. Correlations between anti-HA and anti-NA antibodies titers were weak to moderate but significant (r\n                    <jats:sup>2<\/jats:sup>\n                    =-0.10 to 0.34). Multivariable model outperformed age-only baseline (McFadden R\n                    <jats:sup>2<\/jats:sup>\n                    = 0.19 vs. 0.03; AUC = 0.79 vs. 0.64; likelihood-ratio test \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    = 51, p&lt;10\n                    <jats:sup>-9<\/jats:sup>\n                    ), with anti-HA against A\/H1N1pdm2009 (\u03b2 = 0.78, p &lt; 10\n                    <jats:sup>-6<\/jats:sup>\n                    ) and anti-NA against B\/Victoria (\u03b2 = 0.69, p &lt; 10\n                    <jats:sup>-5<\/jats:sup>\n                    ) emerging as the strongest independent predictors.\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A\/H1N1pdm2009 and B\/Victoria, but not other strains can trigger the autoimmune process leading to orexin cell loss in narcolepsy.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.06.13.26355596","type":"posted-content","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:30:14Z","timestamp":1782239414000},"source":"Crossref","is-referenced-by-count":0,"title":["Antibodies against influenza A\/H1N1pdm2009 and B\/Victoria strains but not A\/H3N2 are increased in recent onset type 1 narcolepsy versus matched controls"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7360-0981","authenticated-orcid":false,"given":"Han","family":"Yan","sequence":"first","affiliation":[{"name":"Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[{"name":"Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Guillard","sequence":"additional","affiliation":[{"name":"Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Macaubas","sequence":"additional","affiliation":[{"name":"Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Pizza","sequence":"additional","affiliation":[{"name":"IRCCS \u2013 Institute of Neurological Science, Bologna, 40139 Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Biscarini","sequence":"additional","affiliation":[{"name":"IRCCS \u2013 Institute of Neurological Science, Bologna, 40139 Bologna, Italy"},{"name":"Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Plazzi","sequence":"additional","affiliation":[{"name":"IRCCS \u2013 Institute of Neurological Science, Bologna, 40139 Bologna, Italy"},{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsee","family":"Mallajosyula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Davis","sequence":"additional","affiliation":[{"name":"Institute of Immunity, Transplantation and Infection, Stanford University, Stanford, CA 94305, USA"},{"name":"Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0795-9946","authenticated-orcid":false,"given":"Holden","family":"Maecker","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6928-5310","authenticated-orcid":false,"given":"Emmanuel","family":"Mignot","sequence":"additional","affiliation":[{"name":"Center for Narcolepsy, Stanford University School of Medicine, Palo Alto, CA 94304"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026062505400763000_2026.06.13.26355596v1.1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.2_Suppl_1.S16"},{"issue":"1","key":"2026062505400763000_2026.06.13.26355596v1.2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41577-023-00902-9","article-title":"The immunopathogenesis of narcolepsy type 1","volume":"24","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"2026062505400763000_2026.06.13.26355596v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/79690"},{"issue":"1","key":"2026062505400763000_2026.06.13.26355596v1.4","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1038\/s41467-023-36120-z","article-title":"Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy","volume":"14","year":"2023","journal-title":"Nat Commun"},{"issue":"12","key":"2026062505400763000_2026.06.13.26355596v1.5","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/acn3.50908","article-title":"Children with Narcolepsy type 1 have increased T-cell responses to orexins","volume":"6","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2026062505400763000_2026.06.13.26355596v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0540-1"},{"issue":"32","key":"2026062505400763000_2026.06.13.26355596v1.7","doi-asserted-by":"crossref","first-page":"e2205797119","DOI":"10.1073\/pnas.2205797119","article-title":"Characterization of T cell receptors reactive to HCRTNH2, pHA273-287, and NP17-31 in control and narcolepsy patients","volume":"119","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026062505400763000_2026.06.13.26355596v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsac137"},{"key":"2026062505400763000_2026.06.13.26355596v1.9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22587"},{"key":"2026062505400763000_2026.06.13.26355596v1.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033536"},{"issue":"8","key":"2026062505400763000_2026.06.13.26355596v1.11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/INF.0000000000002398","article-title":"Narcolepsy and Pandemic Influenza Vaccination: What We Need to Know to be Ready for the Next Pandemic","volume":"38","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"2026062505400763000_2026.06.13.26355596v1.12","doi-asserted-by":"crossref","first-page":"e0204799","DOI":"10.1371\/journal.pone.0204799","article-title":"Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study","volume":"13","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"2026062505400763000_2026.06.13.26355596v1.13","doi-asserted-by":"crossref","first-page":"zsaa172","DOI":"10.1093\/sleep\/zsaa172","article-title":"New 2013 incidence peak in childhood narcolepsy: more than vaccination?","volume":"44","year":"2021","journal-title":"Sleep"},{"key":"2026062505400763000_2026.06.13.26355596v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/nature14460"},{"key":"2026062505400763000_2026.06.13.26355596v1.15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3181-y"},{"key":"2026062505400763000_2026.06.13.26355596v1.16","unstructured":"Webster R , Cox N , St\u00f6hr K. WHO manual on animal influenza diagnosis and surveillance. WHO\/CDS\/CSR\/NCS. Geneva: World Health Organization; 2002:1\u2013105."},{"key":"2026062505400763000_2026.06.13.26355596v1.17","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00417-16"},{"key":"2026062505400763000_2026.06.13.26355596v1.18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.909297"},{"key":"2026062505400763000_2026.06.13.26355596v1.19","unstructured":"World Health Organization. Recommendations for influenza vaccine composition. Geneva: World Health Organization. Accessed February 17, 2026. (https:\/\/www.who.int\/teams\/global-influenza-programme\/vaccines\/who-recommendations.)"},{"key":"2026062505400763000_2026.06.13.26355596v1.20","unstructured":"Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR). Accessed February 17, 2026. (https:\/\/www.cdc.gov\/mmwr\/.)"},{"key":"2026062505400763000_2026.06.13.26355596v1.21","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.043059-0"},{"key":"2026062505400763000_2026.06.13.26355596v1.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1984.tb02144.x"},{"issue":"8800","key":"2026062505400763000_2026.06.13.26355596v1.23","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/0140-6736(92)90571-J","article-title":"DQ (rather than DR) gene marks susceptibility to narcolepsy","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"2026062505400763000_2026.06.13.26355596v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2014.12.010"},{"issue":"8","key":"2026062505400763000_2026.06.13.26355596v1.25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/sleep\/32.8.979","article-title":"Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset","volume":"32","year":"2009","journal-title":"Sleep"},{"key":"2026062505400763000_2026.06.13.26355596v1.26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.sleep.2020.03.019","article-title":"Anti-streptococcal antibodies in Chinese patients with type \u22121 narcolepsy","volume":"72","year":"2020","journal-title":"Sleep Med"},{"issue":"3","key":"2026062505400763000_2026.06.13.26355596v1.27","doi-asserted-by":"crossref","first-page":"zsac325","DOI":"10.1093\/sleep\/zsac325","article-title":"Changed epidemiology of narcolepsy before, during, and after the 2009 H1N1 pandemic: a nationwide narcolepsy surveillance network study in mainland China, 1990-2017","volume":"46","year":"2023","journal-title":"Sleep"},{"key":"2026062505400763000_2026.06.13.26355596v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2018.10.036"},{"issue":"7","key":"2026062505400763000_2026.06.13.26355596v1.29","first-page":"e01385","article-title":"Hemagglutinin and Neuraminidase Antibodies Are Induced in an Age- and Subtype-Dependent Manner after Influenza Virus Infection","volume":"94","year":"2020","journal-title":"J Virol"},{"key":"2026062505400763000_2026.06.13.26355596v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis935"},{"key":"2026062505400763000_2026.06.13.26355596v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz803"},{"key":"2026062505400763000_2026.06.13.26355596v1.32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz411"},{"key":"2026062505400763000_2026.06.13.26355596v1.33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01693-18"},{"key":"2026062505400763000_2026.06.13.26355596v1.34","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a038505"},{"issue":"8","key":"2026062505400763000_2026.06.13.26355596v1.35","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/S2666-5247(24)00066-1","article-title":"Probable extinction of influenza B\/Yamagata and its public health implications: a systematic literature review and assessment of global surveillance databases","volume":"5","year":"2024","journal-title":"Lancet Microbe"},{"key":"2026062505400763000_2026.06.13.26355596v1.36","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.molbev.a004105"},{"issue":"1","key":"2026062505400763000_2026.06.13.26355596v1.37","doi-asserted-by":"crossref","first-page":"6941","DOI":"10.1038\/s41467-023-42541-7","article-title":"Antigen presentation by B cells enables epitope spreading across an MHC barrier","volume":"14","year":"2023","journal-title":"Nat Commun"},{"issue":"4","key":"2026062505400763000_2026.06.13.26355596v1.38","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/vaccines8040630","article-title":"Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines","volume":"8","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"2026062505400763000_2026.06.13.26355596v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/0168-1702(87)90038-4"},{"issue":"43","key":"2026062505400763000_2026.06.13.26355596v1.40","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.15585\/mmwr.mm7143e1","article-title":"Vital Signs: Influenza Hospitalizations and Vaccination Coverage by Race and Ethnicity-United States, 2009-10 Through 2021-22 Influenza Seasons","volume":"71","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"31","key":"2026062505400763000_2026.06.13.26355596v1.41","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1016\/j.vaccine.2023.06.038","article-title":"Intraseasonal waning immunity of seasonal influenza vaccine - A systematic review and meta-analysis","volume":"41","year":"2023","journal-title":"Vaccine"},{"key":"2026062505400763000_2026.06.13.26355596v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70238-X"},{"key":"2026062505400763000_2026.06.13.26355596v1.43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.sleep.2024.02.033","article-title":"Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations","volume":"116","year":"2024","journal-title":"Sleep Med"},{"key":"2026062505400763000_2026.06.13.26355596v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.008"},{"key":"2026062505400763000_2026.06.13.26355596v1.45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108489"},{"issue":"1","key":"2026062505400763000_2026.06.13.26355596v1.46","doi-asserted-by":"crossref","first-page":"21331","DOI":"10.1038\/s41598-025-04049-6","article-title":"Global estimates of vaccine-associated narcolepsy from 1967 to 2023","volume":"15","year":"2025","journal-title":"Sci Rep"},{"key":"2026062505400763000_2026.06.13.26355596v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0143-6"},{"key":"2026062505400763000_2026.06.13.26355596v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01690-w"},{"issue":"5-6","key":"2026062505400763000_2026.06.13.26355596v1.49","first-page":"613","article-title":"Influenza antibodies in the population of the USA; an epidemiological investigation","volume":"8","year":"1953","journal-title":"Bull World Health Organ"},{"key":"2026062505400763000_2026.06.13.26355596v1.50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.11.2029"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.06.13.26355596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:40:22Z","timestamp":1782391222000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.06.13.26355596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":50,"URL":"https:\/\/doi.org\/10.64898\/2026.06.13.26355596","relation":{},"subject":[],"published":{"date-parts":[[2026,6,23]]},"subtype":"preprint"}}